StemImmune LLC

StemImmune LLC is a biotechnology company founded in 2014 and headquartered in the United States. The company specializes in the development and manufacture of high-quality cytokines, recombinant proteins, mediums, and other kits for lab and preclinical research. Its products are widely used in stem cell and immune cell culture and the company is currently focusing on translating these products into human disease treatment, particularly in the field of tumor immunotherapy. StemImmune LLC's offerings also include custom services such as recombinant protein production based on E.coli/mammalian 293 cells, immune cell and stem culture, aiming to meet specific demands of research. The company's slogan emphasizes the value proposition of saving both time and money for researchers. Its vision is to be a trusted supplier for cytokines, proteins, mediums, and other reagents, while the mission is centered on providing the best products and solutions to its customers. Although specific information about the last investment and investors is not available, StemImmune LLC's focus on addressing unmet needs in the fields of life sciences and cell therapy markets indicates potential for growth and deeper market penetration. It is well-positioned to capitalize on the increasing demand for specialized biotech products and services.